Akums Drugs and Pharmaceuticals Q4 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
484.90
0.70 (0.14%)
0.70 (0.14%)Volume4.35 K
Updated: Fri 6 Mar, 2026 | 15:29:56
NSE
474.50
-8.50 (-1.76%)
-8.50 (-1.76%)Volume54.70 K
Updated: Fri 6 Mar, 2026 | 15:25:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 993.41 | 1,070.61 | 6.96% | 3,847.81 | -74.18% |
| Depreciation/ Amortization | 40.00 | 39.65 | -10.16% | 125.64 | -68.17% |
| Operating Income | 62.13 | 88.98 | -23.88% | 330.37 | -81.19% |
| Net Income | 147.62 | 66.32 | 126.47% | -4.04 | 0.00% |
| Other Operating Expenses Total | 138.65 | 144.77 | 24.85% | 59.22 | 134.12% |
| Net Income Before Taxes | 75.14 | 99.57 | -17.48% | -45.28 | 0.00% |
| Total Revenue | 1,055.55 | 1,159.59 | 4.47% | 4,178.18 | -74.74% |
| Selling/ General/ Admin Expenses Total | 183.90 | 189.38 | 4.73% | 894.75 | -79.45% |
| Diluted Normalized EPS | 9.29 | 5.14 | 130.30% | 0.83 | 1024.05% |